AGP Executive Report
Last update: 3 hours agoEbola Response in DRC: The country has started vaccinating frontline health workers in Kisangani, Tshopo, using the Ervebo jab under a compassionate-use framework as the Bundibugyo outbreak keeps surging, with WHO warning the curve is still not bent and community deaths remain a major concern. Vaccine Limits & Trials: Officials say Ervebo is licensed for a different Ebola strain, so 20,000 doses are also earmarked for a Phase 3 trial to test protection against Bundibugyo. WHO Guidance Update: WHO has issued updated temporary recommendations covering surveillance, infection control, clinical care, risk communication, and new rules on social measures, mass gatherings, and domestic mobility. Human Face of the Crisis: A senior DRC incident manager stresses that behind rising case counts are families, and warns treatment centers must be ready as community engagement improves detection. EU4Health Lab Support: HaDEA signed EU4Health contracts to boost Ebola Bundibugyo testing capacity in Kinshasa, including RT-PCR kits and diagnostic devices. Security vs Education: In Goma and Bukavu, the government suspended academic activities in multiple public institutions amid the AFC-M23 security crisis. Policy & Governance: President Félix Tshisekedi announced a “national dialogue” aimed at peace and state reform, starting from the provinces rather than Kinshasa.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
